Spirometer market seen reaching $1.83 billion by 2030

The Business Research Company says the global spirometer market is on track to grow from $1.27 billion in 2025 to $1.37 billion in 2026, then to $1.83 billion by 2030. The report points to rising respiratory disease rates, more home monitoring, and stronger demand for digital diagnostics as the main growth drivers.

Why it matters: - Spirometers help diagnose and track asthma, COPD and other breathing disorders, making them a core tool as respiratory care shifts toward earlier detection and remote monitoring. - The market’s projected growth signals rising demand for lung function testing in hospitals, clinics and home-care settings.

What happened: - The Business Research Company published a spirometer market report on Aug. 30, 2026. - The report estimates the market will grow from $1.27 billion in 2025 to $1.37 billion in 2026, a 7.9% compound annual growth rate. - The report forecasts the market will reach $1.83 billion by 2030, growing at a 7.5% CAGR over the forecast period. - A free sample of the report is available online. - A full version of the spirometer market report is also available.

The details: - Spirometers measure the volume of air inhaled and exhaled, along with exhalation duration. - The devices are used to evaluate lung health and support diagnosis of respiratory conditions. - The report links recent market growth to rising respiratory disorders, expanded pulmonary diagnostic services in hospitals, greater awareness of lung function testing, standardized spirometry guidelines and broader adoption of diagnostic devices. - The report says home-based respiratory monitoring, telehealth-integrated diagnostics, digital healthcare infrastructure, early disease detection and software-driven spirometry platforms will support future growth. - The report highlights digital and connected spirometers, software for lung function analysis, portable and handheld devices, remote monitoring and improved diagnostic precision as key trends. - In 2025, North America held the largest share of the global spirometer market. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspot infographics, and updated graphics and tables.

Between the lines: - The strongest demand appears tied to chronic respiratory disease, which increases the need for repeated testing and longer-term disease management. - The move toward connected and software-enabled devices suggests the market is shifting from simple measurement tools to digital diagnostic platforms. - Data cited in the report from the Australian Institute of Health and Welfare showed respiratory conditions accounted for 7.2% of Australia’s overall disease burden, 8.5% of illnesses causing disability without death and 5.8% of premature deaths in 2023. - That burden helps explain why spirometry remains a relevant screening and monitoring tool for health systems.

What's next: - Market growth is likely to be shaped by adoption of home monitoring, telehealth and portable devices. - The report points to continued demand for standardized, more precise spirometry tools as respiratory care becomes more data-driven. - Health systems and device makers will likely focus on digital integration and remote testing capabilities as the market expands.

The bottom line: - Spirometry is moving deeper into digital and home-based care, and the market outlook suggests steady demand through 2030.